53 related articles for article (PubMed ID: 16211218)
21. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
Mircean C; Tabus I; Kobayashi T; Yamaguchi M; Shiku H; Shmulevich I; Zhang W
Int J Oncol; 2004 Mar; 24(3):497-504. PubMed ID: 14767533
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
[TBL] [Abstract][Full Text] [Related]
23. Diffuse large B-cell lymphomas and burkitt lymphoma.
de Leval L; Hasserjian RP
Hematol Oncol Clin North Am; 2009 Aug; 23(4):791-827. PubMed ID: 19577170
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of immunohistochemistry in identification of prognostically important subgroups (GCB and ABC) in a heterogeneous group of diffuse large B-cell lymphomas--a review article.
Jabłońska J; Jesionek-Kupnicka D
Pol J Pathol; 2008; 59(3):121-7. PubMed ID: 19097355
[TBL] [Abstract][Full Text] [Related]
26. CD5-positive follicular lymphoma: prognostic significance of this aberrant marker?
Mayson E; Saverimuttu J; Cartwright K
Intern Med J; 2014 Apr; 44(4):417-22. PubMed ID: 24754692
[TBL] [Abstract][Full Text] [Related]
27. Tumor progression in malignant lymphomas.
Warnke RA
Bull Cancer; 1991; 78(2):181-6. PubMed ID: 2036489
[TBL] [Abstract][Full Text] [Related]
28. CD5+ diffuse large B-cell lymphoma: a narrative review.
Durani U; Ansell SM
Leuk Lymphoma; 2021 Dec; 62(13):3078-3086. PubMed ID: 34284686
[TBL] [Abstract][Full Text] [Related]
29. Unusual variants of intravascular malignant hematopoietic neoplasms: a report of 4 cases and review of the literature.
Nguyen GH; Yassin AH; Magro CM
Am J Dermatopathol; 2015 May; 37(5):360-7. PubMed ID: 25803724
[TBL] [Abstract][Full Text] [Related]
30. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification.
Pileri SA; Dirnhofer S; Went P; Ascani S; Sabattini E; Marafioti T; Tzankov A; Leoncini L; Falini B; Zinzani PL
Histopathology; 2002 Dec; 41(6):482-509. PubMed ID: 12460202
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic features of intravascular large B-cell lymphoma in Japan: review of the special reference to the Asian variant].
Murase T; Tomita Y; Nakamura S
Rinsho Ketsueki; 2002 Jan; 43(1):5-11. PubMed ID: 11868365
[TBL] [Abstract][Full Text] [Related]
32. Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review.
Zhang X; Sun M; Zhang L; Shao H
Int J Clin Exp Pathol; 2013; 6(5):985-9. PubMed ID: 23638236
[TBL] [Abstract][Full Text] [Related]
33. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
O'Malley DP; Auerbach A; Weiss LM
Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
[TBL] [Abstract][Full Text] [Related]
34. Histopathology in the light of molecular profiling.
Stein H; Hummel M
Ann Oncol; 2006 May; 17 Suppl 4():iv5-7. PubMed ID: 16702185
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in de novo CD5+ diffuse large B cell lymphoma.
Jain P; Fayad LE; Rosenwald A; Young KH; O'Brien S
Am J Hematol; 2013 Sep; 88(9):798-802. PubMed ID: 23695956
[TBL] [Abstract][Full Text] [Related]
36. De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema.
Dargent JL; Lespagnard L; Feoli F; Debusscher L; Greuse M; Bron D
Leuk Lymphoma; 2005 May; 46(5):775-80. PubMed ID: 16019518
[TBL] [Abstract][Full Text] [Related]
37. Aggressive B-cell lymphomas with a primary bone marrow presentation.
Zamò A; Johnston P; Attygalle AD; Laurent C; Arber DA; Fend F
Histopathology; 2020 Sep; 77(3):369-379. PubMed ID: 32324290
[TBL] [Abstract][Full Text] [Related]
38. Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance.
de Leval L; Harris NL
Histopathology; 2003 Dec; 43(6):509-28. PubMed ID: 14636252
[TBL] [Abstract][Full Text] [Related]
39. Graft-versus-lymphoma effects: clinical review, policy proposals, and immunobiology.
Grigg A; Ritchie D
Biol Blood Marrow Transplant; 2004 Sep; 10(9):579-90. PubMed ID: 15319770
[TBL] [Abstract][Full Text] [Related]
40. Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology.
Leoncini L; Delsol G; Gascoyne RD; Harris NL; Pileri SA; Piris MA; Stein H
Histopathology; 2005 Mar; 46(3):241-55. PubMed ID: 15720410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
